Regenxbio (RGNX) Short-term Investments (2015 - 2026)
Regenxbio (RGNX) posted Short-term Investments of $69.03 million for Q2 2026, down 71.7% from $243.74 million a year earlier and down 49.0% from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Short-term Investments (2015 - 2026) Analysis & Trends
At the end of FY2025, Regenxbio's Short-term Investments came in at $195.6 million, up 10.4% from FY2024.
- Annual Short-term Investments shows a five-year compound annual growth rate of 7.3% (FY2020 to FY2025).
- In prior years, Regenxbio's Short-term Investments was $177.16 million in FY2024 (-26.4%), $240.74 million in FY2023 (-10.1%), $267.69 million in FY2022 (+138.5%) and $112.23 million in FY2021 (-18.3%).
- The Q2 2026 figure stands as the lowest quarterly Short-term Investments since Q1 2017.
- On a year-over-year basis, Short-term Investments increased in three of the last eight quarters, with an average decline of 16.9%.
- The strongest year-over-year quarter for Short-term Investments in the past five years was Q2 2022, with growth of 139.3%; the weakest was Q2 2026, with a decline of 71.7%.
- According to Business Quant data, Short-term Investments for the three prior quarters was $135.26 million (Q1 2026), $195.6 million (Q4 2025) and $215.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Regenxbio | 508.48 Mn | -228.57 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 155.18 Mn |
| Jun 30, 2026 | 69.03 Mn |
| Mar 31, 2026 | 135.26 Mn |
| Dec 31, 2025 | 195.60 Mn |
| Sep 30, 2025 | 215.40 Mn |
| Jun 30, 2025 | 243.74 Mn |
| Mar 31, 2025 | 137.77 Mn |
| Dec 31, 2024 | 177.16 Mn |
| Sep 30, 2024 | 198.84 Mn |
| Jun 30, 2024 | 232.59 Mn |
| Mar 31, 2024 | 225.73 Mn |
| Dec 31, 2023 | 240.74 Mn |
| Sep 30, 2023 | 248.84 Mn |
| Jun 30, 2023 | 251.48 Mn |
| Mar 31, 2023 | 261.73 Mn |
| Dec 31, 2022 | 267.69 Mn |
| Sep 30, 2022 | 263.87 Mn |
| Jun 30, 2022 | 281.59 Mn |
| Mar 31, 2022 | 202.26 Mn |
| Dec 31, 2021 | 112.23 Mn |
API Access
Regenxbio Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();